 Robert Dietz
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypothermia, Induced | 6 | 2023 | 66 | 3.700 |
Why?
| | Hypoxia-Ischemia, Brain | 4 | 2023 | 24 | 2.860 |
Why?
| | Brain Ischemia | 9 | 2022 | 299 | 2.600 |
Why?
| | Hippocampus | 11 | 2023 | 693 | 1.500 |
Why?
| | TRPM Cation Channels | 3 | 2021 | 67 | 1.470 |
Why?
| | Heart Arrest | 5 | 2021 | 292 | 1.280 |
Why?
| | Recovery of Function | 3 | 2021 | 574 | 1.160 |
Why?
| | Asphyxia Neonatorum | 2 | 2018 | 15 | 1.120 |
Why?
| | Cerebral Palsy | 2 | 2018 | 80 | 1.050 |
Why?
| | Neurons | 8 | 2019 | 1280 | 0.980 |
Why?
| | Ischemia | 3 | 2023 | 362 | 0.860 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 104 | 0.800 |
Why?
| | Dexmedetomidine | 1 | 2022 | 45 | 0.780 |
Why?
| | Magnesium Sulfate | 2 | 2018 | 16 | 0.750 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2020 | 176 | 0.740 |
Why?
| | Cortical Spreading Depression | 3 | 2010 | 13 | 0.730 |
Why?
| | Infant, Newborn | 10 | 2023 | 5047 | 0.710 |
Why?
| | Long-Term Potentiation | 5 | 2019 | 145 | 0.710 |
Why?
| | Intensive Care, Neonatal | 1 | 2020 | 39 | 0.680 |
Why?
| | Community-Acquired Infections | 1 | 2020 | 141 | 0.620 |
Why?
| | Hypothermia | 1 | 2018 | 38 | 0.610 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2019 | 106 | 0.600 |
Why?
| | Cognitive Dysfunction | 2 | 2019 | 284 | 0.600 |
Why?
| | Zinc | 3 | 2010 | 260 | 0.590 |
Why?
| | Peptide Fragments | 1 | 2021 | 666 | 0.580 |
Why?
| | Membrane Glycoproteins | 1 | 2018 | 430 | 0.510 |
Why?
| | Tinea | 1 | 2014 | 1 | 0.480 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2018 | 395 | 0.470 |
Why?
| | Calcium | 4 | 2017 | 1108 | 0.470 |
Why?
| | Premature Birth | 1 | 2017 | 276 | 0.460 |
Why?
| | Exanthema | 1 | 2014 | 74 | 0.440 |
Why?
| | Resuscitation | 1 | 2016 | 252 | 0.430 |
Why?
| | Animals | 23 | 2023 | 31706 | 0.410 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1395 | 0.410 |
Why?
| | Immunity, Innate | 1 | 2017 | 720 | 0.400 |
Why?
| | Oxidative Stress | 1 | 2017 | 1076 | 0.380 |
Why?
| | Hospitalization | 1 | 2020 | 1752 | 0.380 |
Why?
| | Neuronal Plasticity | 4 | 2023 | 209 | 0.350 |
Why?
| | Mice, Inbred C57BL | 8 | 2021 | 4694 | 0.330 |
Why?
| | Mice | 15 | 2022 | 14869 | 0.320 |
Why?
| | Infant, Premature | 3 | 2018 | 476 | 0.320 |
Why?
| | CA1 Region, Hippocampal | 2 | 2019 | 29 | 0.310 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2021 | 222 | 0.290 |
Why?
| | Cognition | 3 | 2019 | 989 | 0.280 |
Why?
| | Stroke | 3 | 2022 | 1022 | 0.280 |
Why?
| | Sodium-Calcium Exchanger | 1 | 2007 | 13 | 0.280 |
Why?
| | Dendrites | 1 | 2007 | 85 | 0.260 |
Why?
| | Humans | 17 | 2023 | 114686 | 0.240 |
Why?
| | Infant | 4 | 2019 | 7963 | 0.230 |
Why?
| | Male | 15 | 2021 | 55596 | 0.210 |
Why?
| | Multiple Organ Failure | 1 | 2023 | 146 | 0.210 |
Why?
| | Cerebral Infarction | 1 | 2022 | 39 | 0.200 |
Why?
| | Female | 11 | 2021 | 59507 | 0.200 |
Why?
| | Cerebellar Diseases | 1 | 2022 | 21 | 0.200 |
Why?
| | Blood-Brain Barrier | 1 | 2022 | 106 | 0.190 |
Why?
| | Brain | 2 | 2023 | 2371 | 0.190 |
Why?
| | Organ Culture Techniques | 1 | 2021 | 140 | 0.190 |
Why?
| | Morphine | 1 | 2022 | 121 | 0.190 |
Why?
| | Memory Disorders | 2 | 2019 | 155 | 0.180 |
Why?
| | Chelating Agents | 3 | 2010 | 65 | 0.180 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2019 | 60 | 0.160 |
Why?
| | Nogo Proteins | 1 | 2019 | 9 | 0.160 |
Why?
| | Membrane Potentials | 3 | 2010 | 248 | 0.160 |
Why?
| | Heparitin Sulfate | 1 | 2019 | 39 | 0.160 |
Why?
| | Brain Injuries | 2 | 2017 | 461 | 0.160 |
Why?
| | Nerve Net | 1 | 2021 | 226 | 0.160 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2020 | 152 | 0.160 |
Why?
| | Calcineurin | 1 | 2019 | 89 | 0.160 |
Why?
| | Aging | 2 | 2019 | 1618 | 0.150 |
Why?
| | Standard of Care | 1 | 2018 | 62 | 0.150 |
Why?
| | Lateral Ventricles | 1 | 2018 | 24 | 0.150 |
Why?
| | Ouabain | 2 | 2008 | 15 | 0.150 |
Why?
| | Myelin Proteolipid Protein | 1 | 2018 | 61 | 0.150 |
Why?
| | Calcium Channels, T-Type | 1 | 2017 | 16 | 0.150 |
Why?
| | Disease Models, Animal | 3 | 2022 | 3535 | 0.140 |
Why?
| | Mice, Knockout | 3 | 2019 | 2570 | 0.140 |
Why?
| | Magnesium | 1 | 2017 | 145 | 0.140 |
Why?
| | Calcium Channel Blockers | 2 | 2008 | 114 | 0.140 |
Why?
| | In Vitro Techniques | 3 | 2008 | 1016 | 0.140 |
Why?
| | Neuroprotection | 1 | 2017 | 30 | 0.140 |
Why?
| | Age Factors | 2 | 2021 | 2894 | 0.140 |
Why?
| | Infant, Premature, Diseases | 1 | 2018 | 89 | 0.140 |
Why?
| | Gonadal Steroid Hormones | 1 | 2018 | 124 | 0.140 |
Why?
| | Hyperoxia | 1 | 2017 | 99 | 0.140 |
Why?
| | Myelin Sheath | 1 | 2018 | 144 | 0.130 |
Why?
| | Axons | 1 | 2018 | 177 | 0.130 |
Why?
| | Pregnancy | 2 | 2018 | 5518 | 0.130 |
Why?
| | Signal Transduction | 2 | 2019 | 4513 | 0.130 |
Why?
| | Excitatory Postsynaptic Potentials | 1 | 2016 | 98 | 0.130 |
Why?
| | Macaca mulatta | 1 | 2016 | 131 | 0.130 |
Why?
| | Neuroprotective Agents | 1 | 2016 | 104 | 0.120 |
Why?
| | Lung Injury | 1 | 2017 | 198 | 0.120 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 156 | 0.120 |
Why?
| | Behavior, Animal | 1 | 2018 | 458 | 0.120 |
Why?
| | History, 20th Century | 1 | 2016 | 264 | 0.120 |
Why?
| | Action Potentials | 1 | 2017 | 406 | 0.120 |
Why?
| | Enzyme Inhibitors | 2 | 2008 | 750 | 0.120 |
Why?
| | Intestinal Atresia | 1 | 2014 | 16 | 0.110 |
Why?
| | Animals, Newborn | 1 | 2016 | 778 | 0.110 |
Why?
| | Mitochondria | 2 | 2009 | 747 | 0.110 |
Why?
| | Sepsis | 1 | 2019 | 509 | 0.110 |
Why?
| | Brain Injuries, Traumatic | 1 | 2018 | 303 | 0.110 |
Why?
| | Intestine, Small | 1 | 2014 | 122 | 0.110 |
Why?
| | Abnormalities, Multiple | 1 | 2014 | 178 | 0.100 |
Why?
| | Colon | 1 | 2014 | 233 | 0.100 |
Why?
| | Urinary Bladder | 1 | 2014 | 162 | 0.100 |
Why?
| | Peptides | 1 | 2016 | 848 | 0.090 |
Why?
| | Colorado | 1 | 2020 | 4099 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2016 | 1842 | 0.080 |
Why?
| | Adenosine A1 Receptor Antagonists | 1 | 2008 | 2 | 0.080 |
Why?
| | Ethylenediamines | 1 | 2008 | 6 | 0.080 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2008 | 43 | 0.080 |
Why?
| | Electrophysiology | 1 | 2008 | 201 | 0.070 |
Why?
| | Potassium | 1 | 2008 | 128 | 0.070 |
Why?
| | Mice, Inbred Strains | 1 | 2008 | 396 | 0.070 |
Why?
| | Calcium Channels, L-Type | 1 | 2008 | 107 | 0.070 |
Why?
| | Calcium Signaling | 1 | 2009 | 217 | 0.070 |
Why?
| | Nimodipine | 1 | 2007 | 7 | 0.070 |
Why?
| | Glucose | 2 | 2010 | 897 | 0.070 |
Why?
| | N-Methylaspartate | 1 | 2007 | 37 | 0.070 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2007 | 37 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2010 | 695 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2020 | 9088 | 0.070 |
Why?
| | Patch-Clamp Techniques | 1 | 2007 | 239 | 0.070 |
Why?
| | Sodium | 1 | 2007 | 183 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2023 | 2218 | 0.060 |
Why?
| | Membrane Proteins | 1 | 2010 | 1019 | 0.060 |
Why?
| | Aged | 1 | 2022 | 19074 | 0.060 |
Why?
| | Endocarditis, Bacterial | 1 | 2004 | 36 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2020 | 12550 | 0.060 |
Why?
| | Rats | 2 | 2023 | 4958 | 0.050 |
Why?
| | Hypoxia | 1 | 2008 | 958 | 0.050 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 134 | 0.050 |
Why?
| | Sex Factors | 2 | 2018 | 1715 | 0.050 |
Why?
| | Blood Platelets | 1 | 2004 | 351 | 0.050 |
Why?
| | Staphylococcal Infections | 1 | 2004 | 340 | 0.040 |
Why?
| | Cerebellum | 1 | 2022 | 200 | 0.040 |
Why?
| | Thalamic Nuclei | 1 | 2018 | 8 | 0.040 |
Why?
| | Oligodendrocyte Precursor Cells | 1 | 2018 | 18 | 0.040 |
Why?
| | Long-Term Synaptic Depression | 1 | 2018 | 48 | 0.040 |
Why?
| | Memory | 1 | 2019 | 211 | 0.040 |
Why?
| | Receptors, GABA-A | 1 | 2017 | 82 | 0.040 |
Why?
| | Receptors, AMPA | 1 | 2018 | 119 | 0.030 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 144 | 0.030 |
Why?
| | Time Factors | 2 | 2017 | 6115 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2017 | 368 | 0.030 |
Why?
| | Brain Infarction | 1 | 2016 | 22 | 0.030 |
Why?
| | Microglia | 1 | 2018 | 202 | 0.030 |
Why?
| | Cell Death | 1 | 2017 | 323 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1481 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2018 | 380 | 0.030 |
Why?
| | Prune Belly Syndrome | 1 | 2014 | 7 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 591 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 866 | 0.030 |
Why?
| | Syndrome | 1 | 2014 | 333 | 0.030 |
Why?
| | Phosphorylation | 1 | 2017 | 1569 | 0.030 |
Why?
| | Radiography | 1 | 2014 | 812 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2022 | 3052 | 0.020 |
Why?
| | Hypoxia, Brain | 1 | 2010 | 10 | 0.020 |
Why?
| | Potassium Chloride | 1 | 2010 | 32 | 0.020 |
Why?
| | Edetic Acid | 1 | 2010 | 47 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2187 | 0.020 |
Why?
| | Polycyclic Compounds | 1 | 2010 | 14 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2010 | 99 | 0.020 |
Why?
| | Pyramidal Cells | 1 | 2010 | 51 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1342 | 0.020 |
Why?
| | Cation Transport Proteins | 1 | 2010 | 123 | 0.020 |
Why?
| | Membrane Transport Proteins | 1 | 2010 | 138 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2010 | 301 | 0.020 |
Why?
| | Nafcillin | 1 | 2004 | 3 | 0.010 |
Why?
| | Penicillins | 1 | 2004 | 52 | 0.010 |
Why?
| | Staphylococcus | 1 | 2004 | 69 | 0.010 |
Why?
| | Vancomycin | 1 | 2004 | 75 | 0.010 |
Why?
| | Microbial Sensitivity Tests | 1 | 2004 | 300 | 0.010 |
Why?
| | Rabbits | 1 | 2004 | 733 | 0.010 |
Why?
| | Heart | 1 | 2004 | 612 | 0.010 |
Why?
| | Child | 1 | 2019 | 18414 | 0.010 |
Why?
|
|
Dietz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|